AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 32 filers reported holding AN2 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,599,880 | +3.4% | 99,495 | -45.3% | 0.67% | +81.0% |
| Q2 2023 | $1,546,958 | -36.7% | 181,995 | -26.5% | 0.37% | -45.3% |
| Q1 2023 | $2,442,499 | -43.0% | 247,467 | -45.0% | 0.67% | -63.5% |
| Q4 2022 | $4,288,500 | +5.8% | 450,000 | +92.9% | 1.85% | +22.7% |
| Q3 2022 | $4,055,000 | +124.3% | 233,330 | 0.0% | 1.50% | +128.6% |
| Q2 2022 | $1,808,000 | -72.3% | 233,330 | -46.2% | 0.66% | -65.2% |
| Q1 2022 | $6,530,000 | – | 433,330 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,289,320 | $10,959,220 | 1.80% |
| Octagon Capital Advisors LP | 720,900 | $6,127,650 | 0.85% |
| RA Capital Management | 3,773,517 | $32,074,895 | 0.61% |
| BVF INC/IL | 1,563,963 | $13,293,686 | 0.37% |
| Monashee Investment Management LLC | 181,995 | $1,546,958 | 0.37% |
| Avidity Partners Management LP | 657,200 | $5,586,200 | 0.20% |
| Y-Intercept (Hong Kong) Ltd | 14,040 | $119,340 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,500 | $233,750 | 0.01% |
| Alyeska Investment Group, L.P. | 98,426 | $836,621 | 0.01% |
| JANUS HENDERSON GROUP PLC | 1,000,068 | $8,590,578 | 0.01% |